|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Function of apoptosis and expression of the proteins Bcl-2,p53 and C-myc in the development of gastric cancer显示文摘INTRODUCTIONIn China ,the incidence and mortality of gastric cancer rank the second among all cancers. Recent development of cancer [1-20].The aim of this study was investigat the insight of apoptosis and bcl-2, p53 and C-myc protein expression in the development of gastric cancer . | An Gao Xu Shao Guang Li Ji Hong Liu Ai Hua Gan Research Laboratory of Digestive Disease,Huizhou Central People’s Hospital,Huizhou 516001,Guangdong Province,ChinaDr.An Gao Xu graduated from Guangdong Medical College in 1984.He is an associate physician-in-chief,specializing in the research and treatment of gastrointestinal and liver tumors.He has published 24 papers and 1 book. | 2001 | World Journal of Gastroenterology2001，7，3： | 91 |
| 2 | Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection显示文摘AIM To identify the property of dendritic cella (DCs) of peripheral blood monocytes (PBMC) in patlents with chronic HBV infection.METHODS Twenty patients with persistent HBV infectlon were included in this study, 10 healthy subjects being used as a control group. The peripheral blood mononuclear cells (PBMC) of T cell-depleted populations were incubated and induced into mature dendritic cells in the RPMI-1640 medium in the presence of cytokines GMCSF, IL-4, FLt-3, TNF-α and 100 mL@ L-1 of fetal calf serum for a total of 10 - 12 days. The expressions of surface markers on DCs were evaluated using flow cytometric analysis. ELISA method was used to determine the cytokine levels of interleukin-12 (IL-12) and IL-10 in the supernatant produced by DCs. For detection of the stimulatory capacity of DCs to T cell proliferation,mytomycin C-treated DC were incubated with allogenic T cells.RESULTS A typical morphology of mature DCs from healthy subjects and HBV-infected patients was induced in in vitro incubation, but the proliferation ability and cellular number of DCs from HBV-infected patients significantly decreased compared with healthy individuals. In particular, the expression levels of HLADR, CD80 (B7-1) and CD86 (B7-2) on DC surface from patients were also lower than that from healthy individuals (0.46 vs 0.92 for HLA-DR, 0.44 vs 0.88 for CD80 and 0.44 vs 0. 84 for CD86, P< 0.05). The stimulatory capacity and production of IL-12 of DCs from patients in allogenic mixed lymphocyte reaction (AMLR) significantly decreased, but the production level of nitric oxide (NO) by DCa simultaneously increased compared with healthy subjects (86± 15 vs 170±22 μmoI@L 1, P<0.05).CONCLUSION The patients with chronic HBV infection have the defective function and immature phenotype of dendritic cells, which may be associated with the inability of efficient presentation of HBV antigens to host immune system for the clearance of HBV. | Fu-Sheng Wang Li-He Xing Ming-Xu Liu Chuan-Lin Zhu Hui-Gang Liu Hui-Fen Wang Zhou-Yun Lei Division of Biological Engineering,~2 Fourth Department of Liver Diseases,Beijing Institute of Infectious Diseases,Beijing Hospital of Infectious Diseases,Beijing 100039,China | 2001 | World Journal of Gastroenterology2001，7，4： | 131 |
| 3 | 慢性乙型肝炎防治指南显示文摘慢性乙型肝炎是我国常见的慢性传染病之一,严重危害人民健康.为进一步规范慢性乙型肝炎的预防、诊断和治疗,中华医学会肝病学分会和中华医学会感染病学分会组织国内有关专家,在参考国内外最新研究成果的基础上,按照循证医学的原则,制订了<慢性乙型肝炎防治指南>(以下简称<指南>).其中推荐的意见所依据的证据共分为3个级别5个等次[1],文中以括号内斜体罗马数字表示. | Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China | 2005 | 中华肝脏病杂志2005，13，12： | 1932 |
| 4 | 非酒精性脂肪性肝病诊疗指南显示文摘非酒精性脂肪性肝病(NAFLD)是指除外酒精和其他明确的损肝因素所致的,以弥漫性肝细胞大泡性脂肪变为主要特征的临床病理综合征,包括单纯性脂肪肝以及由其演变的脂肪性肝炎(NASH)和肝硬化,胰岛素抵抗和遗传易感性与其发病关系密切。随着肥胖和糖尿病的发病率增加,NAFLD现已成为我国常见的慢性肝病之一,严重危害人民健康。为进一步规范NAFLD的诊断、治疗和疗效评估,中华医学会肝病学分会脂肪肝和酒精性肝病学组组织国内有关专家,在参考国内外最新研究成果的基础上,按照循证医学的原则,制定了《非酒精性脂肪性肝病诊疗指南》(以下简称(《指南》)。其中推荐的意见所依据的证据共分为3个级别5个等次,文中以括号内斜体罗马数字表示,推荐意见的证据分级,参见Ⅸ酒精性肝病诊疗指南》表1。 | Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. | 2006 | 中华肝脏病杂志2006，14，3： | 1509 |
| 5 | 酒精性肝病诊疗指南显示文摘酒精性肝病是由于长期大量饮酒所致的肝脏疾病。初期通常表现为脂肪肝,进而可发展成酒精性肝炎、酒精性肝纤维化和酒精性肝硬化,严重酗酒时可诱发广泛肝细胞坏死甚或肝功能衰竭,该病是我国常见的肝脏疾病之一,严重危害人民健康。为进一步规范酒精性肝病的诊断和治疗,中华医学会肝病学分会脂肪肝和酒精性肝病学组组织国内有关专家,在参考国内外最新研究成果的基础上,按照循证医学的原则,制订了本《指南》。其中推荐的意见所依据的证据等级共分为3个级别5个等次,见表1,文中以括号内斜体罗马数字表示。 | Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. | 2006 | 中华肝脏病杂志2006，14，3： | 271 |
| 6 | 肝衰竭诊疗指南显示文摘肝衰竭是临床常见的严重肝病症候群,病死率极高。多年来,各国学者对肝衰竭的定义、分类、诊断和治疗等问题不断进行探索,但迄今尚无一致意见。2005年美国肝病学会发布了对急性肝衰竭处理的建议,国内迄今尚无肝衰竭的诊断治疗指南。为适应临床工作需要,规范我国肝衰竭的诊断和治疗活动,中华医学会感染病学分会和中华医学会肝病学分会组织国内有关专家,制订了我国第一部《肝衰竭诊疗指南》(以下简称《指南》)。本指南的制定遵守了循证医学原则,借鉴了国内外最新研究成果,力求与国际接轨。其中推荐意见所依据的证据共分为3个级别5个等级(表1),文中以括号内斜体罗马数字表示。 | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association | 2006 | 中华肝脏病杂志2006，14，9： | 827 |
| 7 | 肝纤维化中西医结合诊疗指南显示文摘肝纤维化在国际疾病分类(ICD-10)中可作为一种病名(K74-001),但主要是一种组织病理学概念。肝纤维化指肝组织内细胞外基质(ECM)成分过度增生与异常沉积,导致肝脏结构或(和)功能异常的病理变化,结构上表现为肝窦毛细血管化与肝小叶内以及汇管区纤维化;功能上可以表现为肝功能减退、门静脉高压等。其形成机制主要由于肝炎病毒、乙醇、药物与毒物、血吸虫、代谢和遗传、胆汁淤积、自身免疫性肝病等多种损伤因素长期慢性刺激肝脏,使肝窦内肝星状细胞的活化,胶原等ECM成分代谢失衡,生成大于降解,促使肝脏ECM沉积与组织结构重构。 | Liver Disease Committee,Chinese Association of Integrative Medicine. | 2006 | 中华肝脏病杂志2006，14，11： | 269 |
| 8 | 肝衰竭诊疗指南显示文摘 | Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association | 2006 | 实用肝脏病杂志2006，9，6： | 188 |
| 9 | 非酒精性脂肪性肝病诊疗指南显示文摘 | Fattly Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. | 2007 | 实用肝脏病杂志2007，10，1： | 145 |
| 10 | 睡眠呼吸暂停人群高血压患病率的多中心研究显示文摘目的调查我国睡眠呼吸暂停人群高血压患病情况和影响因素。方法纳入2004至2006年全国20家三甲医院呼吸内科门诊就诊的2297例患者,男:女为1310:211,均经过询问病史、体格检查和多导睡眠监测。统一使用中华医学会呼吸病学分会睡眠呼吸疾病学组编制的《睡眠呼吸暂停与高血压发病情况问卷调查表》对受试者进行问卷和规范的血压测量。应用 SPSS 11.0软件包进行数据分析,采用 X^2检验比较高血压患病率。结果呼吸暂停低通气指数(AHI)<5次/h 组(213例)的高血压患病率(23.5%)明显低于 AHI≥5次/h 组(2084例)的高血压患病率(49.3%);阻塞性睡眠呼吸暂停低通气综合征(OSAHS)人群的高血压患病率为56.2%(569/1012);有高血压家族史人群的高血压患病率为63.7%(450/706),明显高于无家族史者39.4%(627/1591)的患病率;AHI≥5次/h 组的高血压患病几率是 AHI<5次/h 组的3倍(OR=3.167,95%CI 为2.953~5.426,P<0.01);受试人群的高血压患病率随 AHI 增加而增加,自 AHI 16~20次/h 起患病率增高幅度明显加大,AHI 66~70次/h 以后呈下降趋势。经计算得出公式:高血压患病率=0.3199+0.0042×AHI;高血压患病的 OR 值=1.018+0.017×AHI,同时,受试者的高血压患病率随睡眠最低血氧饱和度的减低而明显增高,随嗜睡指数增高而明显增高。受试人群的 AHI 为独立于年龄、性别、体重指数和高血压家族史之外的高血压危险因素。结论睡眠呼吸暂停人群的高血压患病率明显高于无睡眠呼吸暂停人群,睡眠呼吸暂停与高血压患病率有密切的相关关系,是独立于年龄、体重指数和高血压家族史的高血压患病危险因素。 | Sleep Breathing Disorder Group of Respiratory Diseases Branch,Chinese Medical Association | 2007 | 中华结核和呼吸杂志2007，30，12： | 123 |
| 11 | 慢性乙型肝炎防治指南(2010 年版)显示文摘为规范慢性乙型肝炎的预防、诊断和治疗,中华医学会肝病学分会和感染病学分会于2005年组织国内有关专家制订了《慢性乙型肝炎防治指南》。近5年来,国内外有关慢性乙型肝炎的基础和临床研究取得很大进展,为此我们对该指南进行更新。 | Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association | 2011 | 传染病信息2011，24，1： | 95 |
| 12 | 急性病毒性心肌炎的药物治疗观察显示文摘目的 全国十二家大型医院协作观察中西医结合治疗急性病毒性心肌炎疗效。方法 对 10 2 8例临床诊断为急性病毒性心肌炎患者随机各分两组 ,治疗组 60 2例 ,用中西医结合 (黄芪、牛磺酸、泛葵利酮、抗心律失常药等)治疗 ;对照组 4 2 6例 ,用常规 (极化液、抗心律失常药等 )治疗。结果 中西医结合治疗组临床症状改善、外周血肠道病毒阴转、心电图ST T改变及房室传导阻滞、阵发性心房颤动、窦房传导阻滞等恢复均优于对照组(P <0 .0 1、0 .0 5 ) ;对早搏及心功能改善两组间无统计学差异(P <0 .0 5 )。结论 在目前对急性病毒性心肌炎无特效药物治疗的情况下 ,采用中西医结合治疗可作为一种治疗手段。 | Collaborative Group of “Key National Medical Projects for the Ninth Five Year Plan Research” (Correspondence: YANG Yingzhen, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital,Shanghai Medical University,Shanghai 200032) | 1999 | 中华心血管病杂志1999，27，6： | 94 |
| 13 | 慢性乙型肝炎防治指南(2010年版)显示文摘为规范慢性乙型肝炎的预防、诊断和治疗,中华医学会肝病学分会和感染病学分会于2005年组织国内有关专家制订了《慢性乙型肝炎防治指南》[1]。近5年来.国内外有关慢性乙型肝炎的基础和临床研究取得了很大进展.为此我们对该防治指南进行了更新。 | Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. | 2011 | 胃肠病学2011，16，6： | 111 |
| 14 | Antitumor activities of human autologous cytokineinduced killer(CIK)cells against hepatocellular carcinoma cells in vitro and in vivo显示文摘AIM: To characterize the anticancer function of cytokine-induced killer cells (CIK) and develop an adoptiveimmunotherapy for the patients with primary hepatocellularcarcinoma (HCC), we evaluated the proliferation rate,phenotype and the antitumor activity of human CIK cellsfrom healthy donors and HCC patients in vitro and in vivo.METHODS: Peripheral blood mononuclear cells (PBMC) fronhealthy donors and patients with primary HCC were incubatedin vitro and induced into ClK cells in the presence of variouscytokines such as interferon-gamma (IFN-γ), interleukin-1(IL-1), IL-2, and monoclonal antibody (mAb) against CD3.The phenotype and characterization of CIK cells wereidentified by flow cytometric analysis. The cytotoxicity of CIKcells was determined by 51 Cr release assay.RESULTS: The CIK cells were shown to be a heterogeneouspopulation with different cellular phenotypes. Thepercentage of CD3+/CD56+ positive cells, the dominanteffector cells, in total CIK cells from healthy donors andHCC patients, significantly increased from 0.1-0.13 % at day0 to 19.0-20.5 % at day 21 incubation, which suggested thatthe CD3+ CD56+ positive cells proliferated faster than othercell populations of CIK cells in the protocol used in thisstudy. After 28 day in vitro incubation, the ClK cells frompatients with HCC and healthy donors increased by morethan 300-fold and 500-fold in proliferation cell number,respectively. CIK cells originated from HCC patientspossessed a higher in vitro antitumor cytotoxic activity onautologous HCC cells than the autologous lymphokine-activated killer (LAK) cells and PBMC cells. In in vivoanimal experiment, CIK cells had stronger effects on theinhibition of tumor growth in Balb/c nude mice bearing BEL-7402-producing tumor than LAK cells (mean inhibitory rate,84.7 % vs 52.8 %, P < 0.05) or PBMC (mean inhibitoryrate, 84.7% vs37.1%, P<0.01).CONCLUSION: Autologous CIK cells are of highly efficientcytotoxic effector cells against primary hepatocellularcarcinoma cells and might serve as an alternative adoptivetherapeutic strategy for HCC patients. | Fu-Sheng Wang Ming-Xu Liu Bing Zhang Ming Shi Zhou-Yun Lei Wen-Bing Sun Qing-You Du Ju-Mei Chen,Division of Biological Engineering,Beijing Institute of Infectious Diseases,Beijing 100039,China Wen-Bing Sun,Department of Surgery,Beijing Hospital of Infectious Diseases,Beijing 100039,China | 2002 | World Journal of Gastroenterology2002，8，3： | 108 |
| 15 | 狂犬病预防控制技术指南(2016版)显示文摘狂犬病是由狂犬病病毒感染引起的一种动物源性传染病,临床大多表现为特异性恐风、恐水、咽肌痉挛、进行性瘫痪等。近年来,狂犬病报告死亡数一直位居我国法定报告传染病前列,给人民群众生命健康带来严重威胁。为指导基层疾控机构做好狂犬病的预防控制工作,尤其是暴露后的预防处置,降低狂犬病所致死亡,中国疾病预防控制中心组织专家,参考世界卫生组织和美国疾控中心的技术指南,以及国内外最新研究进展,制定了《狂犬病预防控制技术指南(2016版)》。本指南系统回顾了狂犬病的病原学、临床学、实验室诊断、流行病学、疫苗和被动免疫制剂的种类、机制、效果、安全性和不良反应监测与处置,以及暴露预防处置方法等内容的科学证据,在此基础上对狂犬病暴露前和暴露后预防处置的伤口处置、疫苗接种和被动免疫制剂使用等技术给出了推荐建议。本指南适用于从事狂犬病防控工作的各级各类疾病预防控制机构、狂犬病暴露预防处置门诊、医疗机构感染科和急诊科等专业人员。根据狂犬病的国内外研究进展,本指南今后将不断更新、完善。 | Chinese Center for Disease Control and Prevention | 2016 | 中国病毒病杂志2016，6，3： | 84 |
| 16 | 全国艾滋病检测技术规范(2015年修订版)显示文摘前言艾滋病在我国的流行已数十年,随着感染者和临床病人的不断增加、感染人群的变化,艾滋病检测工作量逐渐加大,对监测和检测的需求也不断增加,承担艾滋病检测的实验室已遍及全国各级医疗、疾病预防控制、采供血、妇幼保健机构,出入境检验检疫、军队等各个系统。 | Chinese Center for Disease Control and Prevention | 2016 | 中国病毒病杂志2016，6，6： | 164 |
| 17 | Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection显示文摘Chronic hepatitis B virus (HBV) infection can cause a broad spectrum diseases, including from asymptomatic HBV carriers or cryptic hepatitis, to acute hepatitis, chronic hepatitis, Liver cirrhosis and primary hepatocellular carcinoma. The variable pattern and clinical outcome of the infection were mainly determined by virological itself factors, host immunological factors and genetic factors as well as the experimental factors. Among the human genetic factors, major candidate or identified genes involved in the process of HBV infection fall into the following categories: (1) genes that mediate the processes of viral entry into hepatocytes, induding genes involved in viral binding, fusion with cellular membrane and transportation in target cells; (2) genes that modulate or control the immune response to HBV infection; (3) genes that participate in the pathological alterations in liver tissue;(4) genes involved in the development of liver cirrhosis and hepatocellular carcinoma associated with chronic HBV infection, including genes related to mother-to-infant transmission of HBV infection; and (5) those that contribute to resistance to antiviral therapies. Most of the reports of human genes associated with HBV infection have currently focused on HLA associations. For example, some investigators reported the association of the HLA class Ⅱ alleles such as DRB1*1302 or HLA-DR13 or DQA1*0501-DQB1*0301-DQB1*1102 haplotypes with acute and/or chronic hepatitis B virus infection, respectively. Several pro-inflammatory cytokines such as Th1 cytokines (including IL-2 and IFN-γ)and TNF-α have been identified to participate the process of viral clearance and host immune response to HBV. In contrast, the Th2 cytokine IL-10 serves as a potent inhibitor of Th1 effector cells in HBV diseases. The MBP polymorphisms in its encoding region were found to be involved in chronic infection. Thus, reports from various laboratories have shown some inconsistencies with regard to the effects of host genetic factors on HBV clearance and persistence. Since genetic interactions are complex, it is unlikely that a single allelic variant is responsible for HBV resistance or susceptibility. However, the collective influence of several single nucleotide polymorphisms (SNPs) or haplotype (s)may underlie the natural combinational or synergistic protection against HBV. The future study including the multicohort collaboration will be needed to clarify these preliminary associations and identify other potential candidate genes.The ongoing study of the distributions and functions of the implicated allele polymorphisms will not only provide insight into the pathogenesis of HBV infection, but may also provide a novel rationale for new methods of diagnosis and therapeutic strategies. | Fu-Sheng Wang Division of Biological Engineering,Beijing Institute of Infectious Diseases,100 Xi Si-Huan-Zhong Road,Beijing 100039,China | 2003 | World Journal of Gastroenterology2003，9，4： | 84 |
| 18 | Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis显示文摘AIM To observe the inhibition of antisenseoligonucleotides (asON) phosphorthioate to thetissue inhibitors metalloproteinase-1 (TIMP-1)gene and protein expression in the liver tissue ofimmunologically induced hepatic fibrosis rats.The possibility of reversing hepatic fibrosisthrough gene therapy was observed.METHODS Human serum albumin (HSA) wasused to attack rats, as hepatic fibrosis model, inwhich asONs were used to block the gene andprotein expressing TIMP-1. According to theanalysis of modulator, structure protein, codingseries of TIMP-1 genome, we designed fourdifferent asONs. These asONs were injected intothe hepatic fibrosis models through coccygealvein. The results was observed by RT-PCR formeasuring TIMP-1 mRNA expression,immunohistochemistry and in situ hybridizationfor collagen Ⅰ, Ⅲ, special staining of collagenfiber, and electron microscopic examination.RESULTS Hepatic fibrosis could last within 363days in our modified model. The expressinglevel of TIMP-1 was high during hepatic fibrosisprocess. It has been proved by theimmunohistochemical and the electronmicroscopic examination that the asONphosphorthioate of TIMP-1 could exactly expressin vivo. The effect of colchicine wasdemonstrated to inhibit the expressing level ofmRNA and the content of collagen Ⅰ, Ⅲ in theliver of experimental hepatic fibrosis rats.However, the electron microscopy research andthe pathologic grading of hepatic fibrosisshowed that there was no significant differencebetween the treatment group and the modelgroup (P>0.05).CONCLUSION The experimental rat model ofhepatic fibrosis is one of the preferable modelsto estimate the curative effect of anti-hepaticfibrosis drugs. The asON phosphorthioate ofTIMP-1 could block the gene and proteinexpression of TIMP-1 in the liver of experimentalhepatic fibrosis rats at the mRNA level. It ispossible to reverse hepatic fibrosis, and it isexpected to study a new drug of anti-hepaticfibrosis on the genetic level. Colchicine has verylimited therapeutic effect on hepatic fibrosis,furthermore, its toxicity and side effects areobvious. | Qing He Nie Yong Qian Cheng Yu Mei Xie Yong Xing Zhou Yi Zhan Cao The Center of Infectious Disease Diagnosis and Treatment of PLA,Tangdu Hospital,Forth Military Medical University,Xi’an 710038,Shaanxi Province,ChinaDr,Qing He Nie graduated from Qinghai Medical College as a doctor in 1983,got master degree at Beijing 302 Army Hospital in 1993,got doctor degree at the Third Military Medical University in 1998,engaged in postdoctoral research at the Fourth Military Medical University from 1998 to 2000,now an associate professor,specialized in clinical and experimental research of infectious diseases,had more than 90 papers published,coauthor of ten books,first author of one book. | 2001 | World Journal of Gastroenterology2001，7，3： | 73 |
| 19 | 酒精性肝病诊疗指南显示文摘 | Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. | 2007 | 实用肝脏病杂志2007，10，1： | 73 |
| 20 | 胆汁淤积性肝病诊断治疗专家共识:2015年更新显示文摘胆汁淤积性肝病是一组以胆汁淤积为主要表现的临床常见疾病。近年来,对该病的诊断治疗取得迅速进展。2009年及2013年《中华实验和临床感染病杂志(电子版)》与《中国肝脏病杂志(电子版)》编辑部组织国内部分专家分别对相关资料进行整理分析,形成了《胆汁淤积性肝病诊断治疗专家共识》的2009版及2013版。近2年来,胆汁淤积性肝病诊断治疗的资料进一步积累。 | Expert Committee on the 2015 update of expert consensus on the diagnosis and treatment of cholestatic liver disease | 2015 | 临床肝胆病杂志2015，31，10： | 65 |
您所在的机构暂未开通此部分的功能，请联系管理员